You are here: All Products  > Antengene Approved to Start Trial of Oral CD73 Inhibitor for Solid Tumors

Antengene Approved to Start Trial of Oral CD73 Inhibitor for Solid Tumors

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products